Johan Reizenstein

735 total citations
27 papers, 420 citations indexed

About

Johan Reizenstein is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Johan Reizenstein has authored 27 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Otorhinolaryngology, 11 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Johan Reizenstein's work include Head and Neck Cancer Studies (17 papers), Microbial Inactivation Methods (6 papers) and Cancer Diagnosis and Treatment (5 papers). Johan Reizenstein is often cited by papers focused on Head and Neck Cancer Studies (17 papers), Microbial Inactivation Methods (6 papers) and Cancer Diagnosis and Treatment (5 papers). Johan Reizenstein collaborates with scholars based in Sweden, United Kingdom and United States. Johan Reizenstein's co-authors include Claes Möller, Jan Nyman, Eva Brun, Signe Friesland, Per Nilsson, Helena Sjödin, Björn Zackrisson, Sven Crafoord, Lalle Hammarstedt‐Nordenvall and Per Thunberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Johan Reizenstein

25 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Reizenstein Sweden 11 176 144 122 114 97 27 420
Maximilian Gebhard Germany 12 101 0.6× 55 0.4× 61 0.5× 31 0.3× 97 1.0× 27 379
Shirley Xu United States 12 106 0.6× 44 0.3× 334 2.7× 12 0.1× 95 1.0× 29 496
Nian‐Nian Zhong China 13 55 0.3× 61 0.4× 107 0.9× 12 0.1× 47 0.5× 36 331
Lorna Grove United Kingdom 9 146 0.8× 94 0.7× 150 1.2× 12 0.1× 70 0.7× 15 343
Alim Chin Netherlands 7 63 0.4× 82 0.6× 89 0.7× 16 0.1× 28 0.3× 9 373
Thomas Brunhuber Austria 6 59 0.3× 69 0.5× 217 1.8× 14 0.1× 84 0.9× 10 433
Jan J. Doff Netherlands 7 51 0.3× 66 0.5× 45 0.4× 19 0.2× 75 0.8× 16 218
Isao Kamiyama Japan 7 131 0.7× 98 0.7× 137 1.1× 3 0.0× 107 1.1× 20 397
Siyi Li China 12 120 0.7× 42 0.3× 167 1.4× 7 0.1× 177 1.8× 32 433
Barbara Kofler Austria 10 100 0.6× 79 0.5× 88 0.7× 5 0.0× 132 1.4× 25 368

Countries citing papers authored by Johan Reizenstein

Since Specialization
Citations

This map shows the geographic impact of Johan Reizenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Reizenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Reizenstein more than expected).

Fields of papers citing papers by Johan Reizenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Reizenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Reizenstein. The network helps show where Johan Reizenstein may publish in the future.

Co-authorship network of co-authors of Johan Reizenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Reizenstein. A scholar is included among the top collaborators of Johan Reizenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Reizenstein. Johan Reizenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gebre‐Medhin, Maria, Gabriel Adrian, Per Engström, et al.. (2025). Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer—Mature Results of the ARTSCAN III Trial. International Journal of Radiation Oncology*Biology*Physics. 123(3). 681–690.
2.
Reizenstein, Johan, et al.. (2023). Life-threatening Airway Complication After Radioactive Iodine Treatment: A Case Report and Review of the Literature. Anticancer Research. 43(4). 1853–1855. 1 indexed citations
3.
Högmo, Anders, Helena Sjödin, Maria Gebre‐Medhin, et al.. (2021). A national study of health‐related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma. Head & Neck. 43(12). 3843–3856. 6 indexed citations
4.
Reizenstein, Johan, et al.. (2021). The Role of Electrochemotherapy in Curative Treatment of Head and Neck Cancer and Advanced Skin Cancer: A Need for New Treatment Protocols?. Anticancer Research. 41(8). 3977–3982. 3 indexed citations
5.
Reizenstein, Johan, et al.. (2021). The Value of Post-treatment Surveillance for Detection of Loco-regional Recurrences in Oral Tongue Cancer. Anticancer Research. 41(10). 5059–5063. 1 indexed citations
6.
Gebre‐Medhin, Maria, Eva Brun, Per Engström, et al.. (2020). ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer. Journal of Clinical Oncology. 39(1). 38–47. 98 indexed citations
7.
Reizenstein, Johan, et al.. (2019). Long-term follow-up in patients treated with electrochemotherapy for non-melanoma skin cancer in the head and neck area. Acta Oto-Laryngologica. 139(2). 195–200. 9 indexed citations
8.
Olsson, Caroline, Tufve Nyholm, Elinore Wieslander, et al.. (2019). Initial experience with introducing national guidelines for CT- and MRI-based delineation of organs at risk in radiotherapy. Physics and Imaging in Radiation Oncology. 11. 88–91. 5 indexed citations
9.
Bergqvist, Michael, et al.. (2018). Validation of a Clinical Cancer Register at the Head and Neck Oncology Center in Örebro. Anticancer Research. 39(1). 285–289. 2 indexed citations
10.
Zackrisson, Björn, Elisabeth Kjellén, Karin Söderström, et al.. (2015). Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma – The ARTSCAN trial. Radiotherapy and Oncology. 117(1). 99–105. 23 indexed citations
11.
Reizenstein, Johan, et al.. (2015). Long-term follow-up in patients treated with curative electrochemotherapy for cancer in the oral cavity and oropharynx. Acta Oto-Laryngologica. 135(10). 1070–1078. 35 indexed citations
12.
Reizenstein, Johan, et al.. (2014). Outcome of primary treatment of early laryngeal malignancies using photodynamic therapy. Acta Oto-Laryngologica. 134(8). 852–858. 15 indexed citations
13.
Reizenstein, Johan, et al.. (2014). Electrochemotherapy – possible benefits and limitations to its use in the head and neck region. Acta Oto-Laryngologica. 135(1). 90–95. 19 indexed citations
14.
Karlsson, Leif, et al.. (2011). Pulsed dose rate brachytherapy as the boost in combination with external beam irradiation in base of tongue cancer. Long-term results from a uniform clinical series. SHILAP Revista de lepidopterología. 2 indexed citations
15.
16.
Crafoord, Sven, et al.. (2010). Electroporation Therapy of Skin Cancer in the Head and Neck Area. Dermatologic Surgery. 36(8). 1245–1250. 45 indexed citations
17.
Reizenstein, Johan, et al.. (2010). Electroporation therapy for T1 and T2 oral tongue cancer. Acta Oto-Laryngologica. 131(6). 660–664. 23 indexed citations
18.
Reizenstein, Johan, Stefan Bergström, Lars Holmberg, et al.. (2009). Impact of age at diagnosis on prognosis and treatment in laryngeal cancer. Head & Neck. 32(8). 1062–1068. 22 indexed citations
19.
20.
Nilsson, Christer, et al.. (1995). Photodynamic Therapy for Recurrent Nasopharyngeal Cancer. Archives of Otolaryngology - Head and Neck Surgery. 121(9). 997–1002. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maximilian Gebhard Breakdown of academic impact, for papers by Shirley Xu Breakdown of academic impact, for papers by Nian‐Nian Zhong Breakdown of academic impact, for papers by Lorna Grove Breakdown of academic impact, for papers by Alim Chin Breakdown of academic impact, for papers by Thomas Brunhuber Breakdown of academic impact, for papers by Jan J. Doff Breakdown of academic impact, for papers by Isao Kamiyama Breakdown of academic impact, for papers by Siyi Li Breakdown of academic impact, for papers by Barbara Kofler
Rankless by CCL
2026